Periocular skin hyperpigmentation in children treated with prostaglandin analogues

Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Mohammed Al-ZobidiDeepak P Edward

Abstract

To report periocular skin hyperpigmentation related to prostaglandin analogue (PGA) use in children with glaucoma. This cross-sectional study examined children treated with PGA for at least 6 months between June 2013 and December 2013. The pigmentation scores of the upper eyelids, lower eyelids and cheek were recorded with a chromameter. Hyperpigmentation was defined as a positive difference in scores between the cheek and the upper/lower eyelid. The influence of age, baseline skin pigmentation, duration of PGA, type of PGA and mono- or multitherapy on hyperpigmentation were evaluated. Subjective grading of pigmentation on standardized face photographs and the parent's perception of hyperpigmentation were also recorded. A P value of <0.05 was considered significant. A total of 55 patients were included. Hyperpigmentation of the upper and lower eyelids occurred in all eyes. Subjectively, 26 (47%) eyes had mild and 14 (26%) moderate hyperpigmentation. The upper eyelid showed significantly greater hyperpigmentation than the lower eyelid (P = 0.00004). Chromameter measurements overlapped with pigmentation grading on photographs. The type of and duration of PGA use, PGA mono- or multidrug therapy or baseline skin pigmentation had no...Continue Reading

References

Apr 30, 2003·American Journal of Ophthalmology·Leon W HerndonSanjay Asrani
Aug 2, 2005·Ophthalmology Clinics of North America·Peter J G MarisPeter A Netland
Aug 29, 2006·Ophthalmology·Manali DoshiSmajo Osmanovic
Nov 13, 2008·Photodermatology, Photoimmunology & Photomedicine·Janet Agnes LeeDeepak P Edward
Dec 17, 2008·Survey of Ophthalmology·Albert AlmM Bruce Shields
Feb 14, 2009·Journal of Pediatric Ophthalmology and Strabismus·Greet CoppensIngele Casteels
Jul 23, 2009·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Y TianW Liu
Dec 17, 2009·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Andrew C BlackSharon F Freedman
May 12, 2010·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Jean de RigalVietoria Holloway Barbosa
Jun 11, 2011·Ophthalmic Plastic and Reconstructive Surgery·Tsiang Ung, Zanna I Currie
Mar 14, 2012·Journal of Glaucoma·Lydia ChangPeng Tee Khaw
Dec 5, 2012·Japanese Journal of Ophthalmology·Takaiko YoshinoHaruki Abe
Mar 26, 2013·Journal of Glaucoma·Tomoko Maeda-ChubachiUNKNOWN A6111137 Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Related Papers

Clinical Ophthalmology
Shunsuke NakakuraYoshiaki Kiuchi
Annales de pathologie
Virginie CahnFrançois Plénat
Ophthalmic Plastic and Reconstructive Surgery
Ruben RamirezBita Esmaeli
© 2022 Meta ULC. All rights reserved